YUMANITY THERAPEUTICS INC (YMTX)
US98872L1026 - Common Stock
YUMANITY THERAPEUTICS INC
NASDAQ:YMTX (12/16/2022, 7:00:02 PM)
After market: 1.9 +0.01 (+0.53%)1.89
+0.15 (+8.62%)
Company Profile
Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. The company is headquartered in Boston, Massachusetts and currently employs 40 full-time employees. The company went IPO on 2016-02-11. The firm is focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases. The Company’s pipeline consists of programs focused on Parkinson’s disease, Lewy body dementia, multi-system atrophy, amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), frontotemporal lobar dementia (FTLD), and Alzheimer’s disease. The firm's technology platform enables the rapid screening for disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which results from an aberrant accumulation of misfolded proteins in the brain. The firm's product candidate includes YTX-7739, which is in Phase I clinical trials for the treatment and disease modification of Parkinson's disease.
Company Info
YUMANITY THERAPEUTICS INC
40 Guest Street, Suite 4410
Boston MASSACHUSETTS 02135
P: 16174095300.0
CEO: Richard Peters
Employees: 40
Website: https://www.yumanity.com/
YMTX News
a year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayWe're starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!
a year ago - InvestorPlaceVOD Stock Alert: What to Know as Vodafone Says Goodbye to CEOVodafone (VOD) stock is on the move Monday as investors react to the company's CEO stepping down at the end of the year.
a year ago - InvestorPlaceWhy Are Chinese Stocks Up Today?Chinese stocks are rallying on Monday as investors get more hopeful news of the country loosening its Covid-19 restrictions.
a year ago - InvestorPlaceWhy Is Yumanity Therapeutics (YMTX) Stock Up Today?Yumanity Therapeutics (YMTX) stock is rocketing higher on Monday after the biopharmaceutical company announced a special dividend.
Special dividend estimated to be in range of $1.34 to $1.43 per share Payment of special dividend conditioned upon closing of both Asset Sale and Merger,...
a year ago - Yumanity Therapeutics IncYumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with KinetaYMTX Twits
Here you can normally see the latest stock twits on YMTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
